Literature DB >> 7138735

The acute effects of ethanol on acetanilide disposition in normal subjects, and in patients with liver disease.

J McKay, M D Rawlings, I Cobden, O F James.   

Abstract

1 The effects of single doses (25 g and 50 g) oral ethanol on the disposition of acetanilide (50 mg/kg metabolic active mass) has been studied in normal subjects, and in patients with chronic non-alcoholic liver disease. 2 In normal subjects, ethanol produced a dose-dependent increase in acetanilide half-life, and a decrease in acetenilide clearance. There was a significant correlation (rs = 0.71, P less than 0.01) between the 90 min blood ethanol concentration and the reduction in acetanilide clearance. 3 In patients with liver disease, ethanol produced a similar proportional change in acetanilide half-life and clearance, but these were less consistent. Moreover, liver disease itself was associated with an increase in acetenilide half-life, and a reduction in clearance. 4 It is concluded that single oral doses of ethanol, comparable to those consumed during social drinking, may inhibit some forms of microsomal oxidation and thus have important clinical implications.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7138735      PMCID: PMC1427598          DOI: 10.1111/j.1365-2125.1982.tb02019.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Effect of a single oral dose of methanol, ethanol and propan-2-ol on the hepatic microsomal metabolism of foreign compounds in the rat.

Authors:  G Powis
Journal:  Biochem J       Date:  1975-05       Impact factor: 3.857

2.  Histological changes in the liver and indices of drug metabolism in alcoholics.

Authors:  E A Sotaniemi; J Ahlqvist; R O Pelkonen; H Pirttiaho; P V Luoma
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

3.  The pharmacokinetics of acetanilide and of diphenylhydantoin sodium.

Authors:  J L Cunningham; M F Bullen; D A Evans
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

4.  Spectral studies of drug interaction with hepatic microsomal cytochrome.

Authors:  J B Schenkman; H Remmer; R W Estabrook
Journal:  Mol Pharmacol       Date:  1967-03       Impact factor: 4.436

5.  Increase of ethanol, meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats.

Authors:  P S Misra; A Lefévre; H Ishii; E Rubin; C S Lieber
Journal:  Am J Med       Date:  1971-09       Impact factor: 4.965

6.  Interaction of ethanol and pyrazole with hepatic microsomes.

Authors:  E Rubin; H Gang; C S Lieber
Journal:  Biochem Biophys Res Commun       Date:  1971-01-08       Impact factor: 3.575

7.  Involvement of a hydrophobic site in the inhibition of the microsomal p-hydroxylation of aniline by alcohols.

Authors:  G M Cohen; G J Mannering
Journal:  Mol Pharmacol       Date:  1973-05       Impact factor: 4.436

Review 8.  Hepatic and metabolic effects of alcohol (1966 to 1973).

Authors:  C S Lieber
Journal:  Gastroenterology       Date:  1973-11       Impact factor: 22.682

9.  The effect of inhibitors of alcohol metabolism upon the changes in the hepatic microsomal metabolism of foreign compounds produced by the acute administration of some alcohols to the rat.

Authors:  G Powis; L Grant
Journal:  Biochem Pharmacol       Date:  1976-10-01       Impact factor: 5.858

10.  Determinants of serum antipyrine half-lives in patients with liver disease.

Authors:  R A Branch; C M Herbert; A E Read
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

View more
  2 in total

1.  Alcohol and bupropion pharmacokinetics in healthy male volunteers.

Authors:  J Posner; A Bye; S Jeal; A W Peck; P Whiteman
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

2.  The metabolism of 7-ethoxycoumarin in human liver microsomes and the effect of primary biliary cirrhosis: implications for studies of drug metabolism in liver disease.

Authors:  K W Woodhouse; H C Mitchison; E Mutch; P D Wright; M D Rawlins; O F James
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.